To study the clinical presentation of homoeopathic management of paraplegia in adult age group.

Study of Homoeopathic Management of Paraplegia in Adult Age Group - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058008

Enrollment

Registered

2023-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

Intervention1: Homoeopathic Medicines: Arnica, Rhus tox, Hypericum, Causticum, Conium mac, Thalium, Plumbum met : Potency: 30,200 Dose: twice a day and S.O.S Duration: 3 months Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: Pre Diagnosed Cases Of Paraplegia Cases having clinical features of Paraplegia.

Exclusion criteria

Exclusion criteria: CASES WITH IRREGULAR ORGAN DAMAGE OR REQUIRING CRITICAL CARE . IRREGULAR FOLLOW UPS

Design outcomes

Primary

Measure	Time frame
Enhancement in neurological recoveryTimepoint: 15 days	—

Secondary

Measure	Time frame
Avoid deterioration of vital organs & psychological improvementTimepoint: 4 months	—

Countries

India

Contacts

Public ContactDr Smit Dad

Jawaharlal nehru homoeopathic medical college

devendra.javad12677@paruluniversity.ac.in9825222758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026